PharmAssistant
PharmAssistant is a French AI assistant for community pharmacists. Sixty-one in-house tools query over 110 official drug databases and learned societies live, and every answer cites the sources it actually consulted. Hosted in France, browser-only.
What is PharmAssistant?
PharmAssistant is a French-language conversational AI assistant built for community pharmacy. It is published by Johan Natter, a sole trader who holds doctorates in pharmacy and in medicinal chemistry, and it is sold by subscription to pharmacies rather than to individual seats.
Its central claim is architectural. Instead of letting a language model answer from memory or from a plain web search, every question goes through a two-stage engine: a routing model decides which of the 61 in-house tools to call, those tools genuinely query the reference sources, and a second model writes the answer from what was actually read. More than 110 sources sit behind them, including French summaries of product characteristics and the public drug database, the ANSM drug interaction thesaurus, RCPlus (an in-house engine that reads interaction sections of French product summaries where the thesaurus is silent), CRAT and LactMed for pregnancy and breastfeeding, HAS guidance, Legifrance, Meddispar, the reimbursable devices list, CredibleMeds, LiverTox, STOPP/START, DrugCentral, Orphanet and PubMed, plus 13 regional good-use observatories, 52 learned societies and 83 curated professional websites for second-line web search. Each answer displays the references it consulted, and they open in one click.
The chat carries a tool panel: a 157-card dermatology atlas filtered entirely in the browser, a mycology atlas, a paediatric dose calculator, dose equivalences across 21 drug classes, 17 clinical scores, rapid test questionnaires, 113 laboratory parameters, renal function estimation, crushability data for 633 products, over 1,100 dispensing advice cards and a 16-language medical translation mode. Eight paid patient interviews of the French pharmacy convention are templated, scored and exported as PDFs on the pharmacy's own letterhead. A separate, non-clinical assistant, powered by a model from OpenAI or Anthropic served from the EU, handles drafting and image creation on the Expert and Officine plans.
The publisher's own benchmark of 31 July 2026 scores it 197 correct answers out of 200 against six consumer AI systems, and publishes the full question set. It is a browser service with no installation, plus a key-authenticated public API.
What it does
- Answer a counter question with a sourced, verifiable reply in about a minute, every consulted reference listed underneath
- Cross-check an interaction, a dose equivalence, a renal adjustment, a QT risk or an anticholinergic burden against the official French references
- Read a photographed prescription into a line-by-line correctable table, with built-in patient redaction
- Run one of the eight paid patient interviews of the French pharmacy convention and export the file as a PDF on the pharmacy letterhead
- Check reimbursement, generic groups, LPP codes, dispensing status and current ANSM shortages
- Print patient advice sheets, nutrition sheets, clinical scores and rapid diagnostic test questionnaires
- Draft emails, letters to health authorities and window posters through a separate non-clinical assistant
When to use PharmAssistant / When not to
A quick filter to help you decide if PharmAssistant is the right fit.
When to use PharmAssistant
- Community pharmacy owners who want one subscription covering the whole team rather than a per-seat licence
- Pharmacists at the counter who need an exact, citable value in seconds: interaction level, generic substitution group, reimbursement rate, LPP code, current ANSM shortage
- Pharmacy technicians and locums who want a second opinion on crushing a tablet, an inhaler technique or a paediatric dose
- Pharmacists running the paid patient interviews of the French pharmacy convention, from the official form to the printable PDF file
- Software vendors and pharmacy groups wanting to embed a sourced pharmaceutical answer engine into their own product through the API
When not to use PharmAssistant
- Anyone outside France: the licence is granted for French territory only and the reference corpus is overwhelmingly French
- Non-French speakers: the interface, the answers and every legal document are in French, with no English version
- Patients and the general public: the service is contractually restricted to healthcare professionals
- Any workflow involving identifiable patient data: transmitting it is contractually forbidden and the service holds no HDS health-data hosting certification
- Buyers who need a service-level agreement, a signed data processing agreement or a clinically certified medical device
How to use PharmAssistant
A typical end-to-end flow, from setup to results.
- Try it with no account at all from the free trial page: a few real counter questions each day, no email and no card required
- Or create an account in about two minutes, in the pharmacy's name or as an individual, the pharmacy name being optional
- Use the seven-day full trial, which needs no bank card and does not auto-renew: access simply stops at the end
- Ask the question in plain language, as you would ask a colleague, and read the sources listed under the answer
- Switch on Detailed mode from the message box when the case is complex, such as polypharmacy, pregnancy or oncology
- Photograph a prescription from a phone, check the transcribed table line by line and correct any misread line before searching
- Open the tool panel for the atlases, calculators, clinical scores and printable advice sheets
- Run a patient interview from the panel, let the scores compute, then export the PDF on your pharmacy letterhead
- As the owner, set house instructions, partner ranges, key products and per-user guidance in the administration area, then invite colleagues by email
- For programmatic access, email the publisher, then generate your own pa_ key on the secure portal and call the API with the X-API-Key header
Pros & Cons
Pros
- Every answer names the references actually consulted, and they open in one click, which makes a counter answer verifiable rather than merely plausible
- Exact values are pulled from the official French databases rather than from model memory, so the same question returns the same sources
- The accuracy benchmark is published with its full 200-question set, including the three questions the tool gets wrong
- Data is hosted in France at Scaleway, inference runs in the EU, and the terms state that requests are never used to train the models
- The subprocessor list is nominative and detailed provider by provider, with location, guarantees and training stance for each
- Genuinely free entry: daily questions with no account and no email, then a seven-day full trial without a bank card
- Priced per pharmacy rather than per seat, with no commitment, cancellation in two clicks and no VAT added
Cons
- French territory only: the licence is granted for France, the corpus is French, and there is no English interface or documentation
- A very young product from a sole trader registered on 8 July 2026, with a first web archive capture on 28 August 2026
- No service-level agreement, warranties are given as-is, and liability is capped at twelve months of subscription, or 100 EUR during the trial
- No customer-facing data processing agreement is published or offered, and no data protection officer is appointed
- The 98% accuracy figure is produced by the publisher on its own question set, with no independent verification
- No native mobile app and no HDS health-data hosting certification, which rules out any use on identifiable patient records
- API pricing is not public: it is quoted per question and agreed in writing case by case
Pricing & Plans
A permanently free entry point is available: a limited number of questions can be asked each day from the trial page without an account, an email address or a bank card, and every new account additionally receives a seven-day full trial with no card and no automatic renewal. Paid access starts at 19.90 EUR per month for the Comptoir plan, which covers the whole pharmacy rather than a single seat. The Expert plan is 39.90 EUR per month and the Officine plan 139.90 EUR per month. No VAT is added, the publisher operating under the French small-business exemption. Payment is handled by Stripe, billing is monthly and cancellation takes two clicks. API access is billed per question at a rate agreed in writing, with no public price.
- 1
- 200 counter questions
- 150 Detailed mode answers and 240 image analyses per month
- all sources and tools
- patient interviews
- one account (the owner)
- 3
- 000 questions
- 450 Detailed mode answers
- 600 image analyses
- 450 general-purpose AI questions and 120 image creations per month
- owner plus five colleagues
- both email digests
- partner ranges
- unlimited questions
- Detailed mode
- image analyses
- general-purpose AI and image creation under a fair-use clause
- unlimited accounts
- individually named key products
- four answer-length settings
- priority processing at peak hours
- 20 questions
- 5 detailed answers and 3 image analyses per day
- 10 general-purpose AI questions
- both email digests
- up to five colleague accounts
Data, GDPR & hosting
A consolidated view of how PharmAssistant handles your data.
GDPR overview
GDPR implementation is documented in unusual detail for a one-person publisher. The privacy policy, version 2026.12 updated in August 2026, names the controller, the four legal bases, nine subprocessors with their identity, location and guarantees, and twelve retention periods. Access, rectification, erasure, restriction, JSON portability, objection, consent withdrawal and post-mortem instructions are all listed, exercisable in-app or by email within one month. Breach handling follows Articles 33 and 34, with CNIL notification within 72 hours. No data protection officer is appointed, the publisher stating it is not required; the contact address serves instead. Each policy version is frozen and archived with a SHA-256 hash, and a substantial change is resubmitted for acceptance at login.
Who owns the data?
Johan Natter, the sole trader publishing the tool, is the data controller for accounts, conversations, uploaded images and usage data. Users keep ownership of what they submit and grant only a limited licence, for the duration of use, allowing the publisher and its subprocessors to deliver the service. Two carve-outs go the other way: for the interview templates, the saved interview records and the local identity book, the pharmacist is the sole controller and the publisher acts only as a processor on instruction. API customers who act as controllers get the same arrangement under Article 28. Feedback and suggestions, by contrast, become freely exploitable by the publisher.
Reuse rights
Answers may be reused freely in professional practice without asking permission, subject to the terms. Two conditions apply: reuse outside the application, in a document or a communication medium, must state that the content was AI-generated, and answers may not be used to build, train or benchmark a competing service, an obligation that survives five years after the account closes. Bulk extraction of answers, cited sources or database content is likewise forbidden, and the publisher formally opts out of text and data mining on its corpus. Submitted questions are used only to answer them and to run the service; the terms state they are never used to train the AI models, and usage statistics feed quality and product improvement.
Data retention & training
Hosting summary
Servers, conversations and logs are hosted in France by Scaleway SAS, 8 rue de la Ville l'Eveque, 75008 Paris, in an environment isolated per pharmacy; the privacy policy describes Scaleway as an ISO 27001 certified host, a certification held by the host and not by the publisher. AI generation runs inside the European Union. Mistral AI processes entirely within the EU. TensorX runs inference on EU infrastructure in Dublin and Helsinki with zero data retention. OpenAI and the OpenRouter gateway are restricted by the publisher to European endpoints only. Google contracts through its Irish entity, but an intervention by Google LLC in the United States remains possible, covered by the EU-US Data Privacy Framework and standard contractual clauses. Stripe Payments Europe in Dublin handles payment, Brevo in France routes emails, and Serper in the United States receives only reformulated search keywords, never the full question, the conversation history or any image.
Where PharmAssistant works
Country-level availability.
Available in
Things to keep in mind
Risks and trade-offs to weigh before adopting PharmAssistant.
- Transmitting anything that identifies a patient is contractually forbidden and described as an essential condition of the contract; breaching it exposes the user to suspension and to an indemnity clause
- Answers are AI-generated and the terms warn that errors, omissions and hallucinations are possible: the pharmacist is required to verify systematically, and the pharmaceutical analysis remains the pharmacist's own regulated act
- Convenience can erode habit: a tool that answers in a minute what took ten makes it tempting to stop opening the primary source, exactly when a wrong value would be hardest to notice
- The ISO 27001 certifications quoted belong to Scaleway as host and to TensorX as inference infrastructure, and the PCI-DSS level 1 certification belongs to Stripe; the publisher claims none of them for itself
- OpenRouter and Serper are established in the United States, and an intervention by Google LLC remains possible, so residual transfers exist despite EU-only inference
- The unlimited Officine plan is bounded by a fair-use clause, and no pro-rata refund is given for a started period
- User claims against the publisher are contractually time-barred after twelve months, a shortened limitation period worth knowing before a dispute arises
Setup & Integrations
Technical difficulty
Very low. Nothing is installed: the service runs in any browser on desktop, tablet or phone, updates itself and needs no maintenance from the pharmacy. The anonymous trial requires not even an email address, and creating an account is announced as a two-minute step, with the pharmacy name optional. Optional owner configuration covers house instructions, partner ranges, key products, the document library and the logo on PDF exports; colleagues are invited by email. Only the API needs developer work: request access, generate a key on the portal, then call it with a supplied client library.
Deployment
Supported languages
Behind PharmAssistant
Social
Resources
All the official URLs gathered for verification and reference.
Alternatives
Tools that compete with or complement PharmAssistant.
Frequently asked questions
Who publishes PharmAssistant?
How much does it cost, and is anything free?
Where is the data hosted, and does it train the models?
How long is data kept?
Can patient data be entered?
Is it a medical device, and is it HDS certified?
Is there an API?
Does anything need to be installed?
Where can it be used?
How accurate is it?
Should you pick PharmAssistant?
PharmAssistant is a narrow, opinionated tool that bets on a single idea: for the questions that turn on an exact value, deterministic business tools beat a general model with a web connection. The bet is testable, and the publisher makes it testable, publishing its whole 200-question benchmark including the items it fails. That intellectual honesty extends to the legal pages, where the privacy policy names nine subprocessors one by one, gives twelve retention periods in days and years, and spells out which side of the controller-processor line each feature falls on. That level of detail is unusual for a publisher this small.
The counterweights are equally clear. This is a sole trader registered on 8 July 2026 whose site first appeared in the web archive seven weeks later, offering no service-level agreement, no customer data processing agreement and no appointed data protection officer, with liability capped at twelve months of subscription. The product is deliberately confined to French territory, in French, for French pharmacy law and French reimbursement rules; nothing about it travels. Its accuracy claim, however transparently documented, is self-produced. And the whole design rests on a contractual prohibition, that no identifiable patient data ever enters the service, which is what lets the publisher stay outside both the medical device regime and HDS health-data hosting certification. That boundary is enforced by terms and by tooling, but ultimately by the pharmacist.
For a French community pharmacy, the entry price is low, the trial is genuinely free and the scope of the reference corpus, down to veterinary medicines, foreign packs and reimbursable devices, is wider than the price suggests. For anyone else, it is simply not the tool.
- Choosing a selection results in a full page refresh.
- Opens in a new window.